A shrinking pool of assets on the local bourse and greater regulatory scrutiny on foreign buyers will see more bidders teaming up in consortiums to take assets private, predicts law firm Corrs Chambers Westgarth.
In an interview with this column outlining the M & A outlook for the next 12 months, Corrs head of corporate Sandy Mak said consortium bids had been popular in 2026 with assets like Healthscope , Qube , and Steadfast all scooped up by groups of buyers.
Gift articles to anyone you choose each month when you subscribe.